AI assistant
Morepen Laboratories Ltd. Capital/Financing Update 2021
59389_rns_2021-07-27_8a7a5d63-38f5-4fe3-af03-1d2d80248ad2.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Date: 27/07/2021
To,
National Stock Exchange of India Ltd. Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051 Symbol: MOREPENLAB
BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 500288
Subject: Statement of deviation or variation in utilization of funds raised pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dear Sir/ Madam,
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please note that there is no deviation or variation in utilization of funds raised, in the quarter ended June 30, 2021.
Please find enclosed nil statement of deviation or variation in this regard.
You are requested to take the note of the same in your record.
Encl.: As above
| MOREPEN | |
|---|---|
| ---------------- | -- |
| STATEMENT OF DEVIATION / VARIATION IN UTILISATION OF FUNDS RAISED | |||||||
|---|---|---|---|---|---|---|---|
| Name of listed entity | Morepen Laboratories Limited |
||||||
| Mode of Fund Raising | Preferential issues of Fully Convertible Warrants |
||||||
| Date of Raising Funds | 26-03-2021 | ||||||
| Amount Raised | Rs. 4375 Lakh $(i.e., 25\% of issue price)$ |
||||||
| Report filed for Quarter ended | 30-06-2021 | ||||||
| Monitoring Agency | Not Applicable | ||||||
| Monitoring Agency Name, if applicable | Not Applicable | ||||||
| Is there a Deviation / Variation in use of funds raised |
No | ||||||
| If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders |
Not Applicable | ||||||
| If Yes, Date of shareholder Approval | Not Applicable | ||||||
| Explanation for the Deviation / Variation | Not Applicable | ||||||
| Comments of the Audit Committee after review |
|||||||
| Comments of the auditors, if any | (Rs. in Lakh) | ||||||
| Objects for which funds have been raised and where there has been a deviation, in the following table |
Remarks | ||||||
| Original Object | Modified Object, if any | Original Allocati on |
Modifie d allocatio n, if any |
Funds Utilise d |
Amount of Deviation/Variation for the quarter according to applicable object |
if any | |
| The funds shall be utilized towards capital capital, working expenditure/ business expansion for existing project, new project and research including development, payment of liabilities including settlement with Banks/ financial institutions and such other purpose as the Board may decide. |
Not applicable | Rs. 4375 | Not applicab le |
Rs. 4346 |
Not applicable | No deviation |
Deviation or variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund-raising document i.e., prospectus, letter of offer, etc
For Morepen Laboratories Limited
Ajay Sharma Chief Financial Officer
Date: 27-07-2021 Place: New Delhi
Morepen Laboratories Limited
Corp. Off.: 4th Floor, Antriksh Bhawan, 22 K.G.Marg, New Delhi- 110 001, INDIA
Tel.:+91-11-23324443,23712025, E-mail: [email protected], Website: www.morepen.com
CIN NO. L24231 HP1984PLC006028
Plant & Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205
Tel.: +91-1795-266401-03, 244590, Fax: +91-1795-244591, E-mail: [email protected]